Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27917295)

Published in J Pathol Clin Res on June 28, 2016

Authors

Emmanuelle Jeannot1, Véronique Becette2, Maura Campitelli3, Marie-Ange Calméjane1, Emmanuelle Lappartient1, Evelyne Ruff2, Stéphanie Saada1, Allyson Holmes4, Dominique Bellet2, Xavier Sastre-Garau5

Author Affiliations

1: Department of Biopathology Institut Curie 75248 Paris Cedex 05 France.
2: Department of Biopathology Institut Curie 92210 St Cloud France.
3: Department of Radiotherapy Institut Curie 75248 Paris Cedex 05 France.
4: Institut Curie, PSL Research University, Centre National de la Recherche Scientifique, UMR 3244, Sorbonne Universités Paris France.
5: Department of Biopathology Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne-CS30519, 54519 Vandoeuvre-les-Nancy France.

Articles cited by this

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

Human papillomavirus and cervical cancer. Lancet (2007) 12.47

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36

Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer (2011) 7.69

Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A (2005) 5.91

Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76

Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods (2013) 3.63

Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One (2013) 3.53

Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res (2007) 3.05

Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol (2008) 1.88

Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol (2004) 1.41

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol Med (2015) 1.37

Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol (2010) 1.30

Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis. Cancer Res (2005) 1.14

Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev (2002) 1.09

Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer (2001) 0.97

HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol (2004) 0.92

Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol (2005) 0.90

Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One (2012) 0.89

Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer (2004) 0.88

Human papillomavirus DNA in sera of cervical cancer patients as tumor marker. Cancer Lett (2003) 0.85

Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecol Oncol (2009) 0.83

Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer (2015) 0.78